PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 69 filers reported holding PROQR THRAPEUTICS N V in Q3 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $806,000 | -19.7% | 620,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,004,000 | -24.0% | 620,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $1,321,000 | -42.4% | 620,000 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $2,294,000 | +397.6% | 620,000 | 0.0% | 0.00% | +200.0% |
| Q3 2022 | $461,000 | -4.4% | 620,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $482,000 | -14.1% | 620,000 | 0.0% | 0.00% | – |
| Q1 2022 | $561,000 | -88.7% | 620,000 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $4,966,000 | -4.3% | 620,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,189,000 | +24.2% | 620,000 | 0.0% | 0.00% | +33.3% |
| Q2 2021 | $4,179,000 | +2.0% | 620,000 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $4,098,000 | +45433.3% | 620,000 | +21279.3% | 0.01% | – |
| Q4 2017 | $9,000 | – | 2,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |